DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 0.00 0.00%
S&P 500 2,072.83 5.80 0.28%
market minute promo

194.72 1.95 (1.01%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ALXN $194.72 1.01%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $193.28
Previous Close $192.77
Daily Range $191.52 - $194.99
52-Week Range $120.14 - $197.64
Market Cap $38.6B
P/E Ratio 81.13
Dividend (Yield) $0.00 (0.0%)
Volume 704,468
Average Daily Volume 1,055,534
Current FY EPS $4.72





Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website:

News & Commentary Rss Feed

Is This Trend Making Gilead Sciences, Inc. Worry?

In a bid to control costs, healthcare payers are restricting who can be prescribed Gilead Sciences' Harvoni.

Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog

Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog

Mixed Readings For Biotech Short Interest

Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer

US Stock Futures Edge Higher Ahead Of GDP, Housing Data

Stock Market News for November 19, 2014 - Market News

Why Celldex Therapeutics' Stock Is Now Ready For Takeoff

Gilead Has Been Rocked After Earnings, But I'm Looking To Buy!

Molecular Biology Meets Finance: MLV's George Zavoico On Ebola's Silver Lining

Biotech Short Interest Becomes Stock Specific

Earnings Triple Plays

See More ALXN News...

ALXN's Top Competitors

ALXN $194.72 (1.01%)
Current stock: ALXN
AMGN $164.72 (1.53%)
Current stock: AMGN
GILD $100.30 (-0.80%)
Current stock: GILD
BIIB $304.92 (-0.16%)
Current stock: BIIB